Role of neprilysin in the pathogenesis of Alzheimer's disease

Progress in Biochemistry and Biophysics

Volumn 39, Issue 8, 2012, Pages 721-725

  Yang, Hong Qi ^a,b   Xing, Ying ^b  

^a Department of Neurology   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

amyloid (A ); A degrading enzymes (ADEs); Alzheimer's disease (AD); Neprilysin (NEP)

Indexed keywords

EID: 84870863692     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2012.00034     Document Type: Review

References (49)

1. He R Q, Lu J, Miao J Y. Formaldehyde stress. Sci China Life Sci, 2010, 53( 12): 1399-1404
2. Tong Z Q, Zhang J L, Luo W H, et al. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia. Neurobiol Aging, 2011, 32 ( 1) : 31-41
3. Zhou J W. Recent progress in neurodegenerative disorder research in China. Sci China Life Sci, 2010, 53( 3): 348-355
4. Liu Y, Qiang M, Wei Y, et al. A novel molecular mechanism for nitrated α-synuclein-induced cell death. J Mol Cell Biol, 2011, 3( 4): 239-249
5. Naqvi S H, Wang W S, Miao J Y, et al. Prog Biochem Biophys, 2010, 37( 11): 1195-1203
6. Zhang X H, Poo M M. Progress in neural plasticity. Sci China Life Sci, 2010, 53( 3): 322-329
7. Luo Z G. Synapse formation and remodeling. Axon guidance and neuronal migration research in China. Sci China Life Sci, 2010, 53( 3): 315-321
8. Zhang M, Zhao Z M, He L, et al. A meta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci, 2010, 53( 1): 112-124
9. Sun P, Zhang Q, Han J Y, et al. TLR4 signaling induced TLR2 expression in the process of mimic cerebral ischemia/reperfusion in vitro. Sci China Life Sci, 2010, 53( 2): 223-228
10. Wang Y Z, Xu T L. Ion channels in neuronal survival. Sci China Life Sci, 2010, 53( 3): 342-347
11. Xu S J, Liu G L. Prog Biochem Biophys, 2010, 37( 6): 589-593
12. Luo Y F, Zhang J, Liu N Q, et al. Copper ions influence the toxicity of β-amyloid (1-42) in a concentration-dependent manner in a Caenorhabditis ele gans model of Alzheimer' s disease. Sci China Life Sci, 2011, 54( 6): 527-534
13. Mulder S D, Veerhuis R, Blankenstein M A, et al. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes. Exp Neurol, 2012, 233( 1): 373-379
14. Mawuenyega K G, Sigurdson W, Ovod V, et al. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science, 2010, 330( 6012): 1774
15. Iwata N, Tsubuki S, Takaki Y, et al. Identification of the major Aβ42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nat Med, 2000, 6(2): 143-150 (Pubitemid 30082357)
16. Takaki Y, Iwata N, Tsubuki S, et al. Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid β peptide in the brain. J Biochem, 2000, 128(6): 897-902 (Pubitemid 32011559)
17. Iwata N, Tsubuki S, Takaki Y, et al. Metabolic regulation of brain Aβ byneprilysin. Science, 2001, 292( 5521): 1550-1552
18. Mouri A, Zou L B, Iwata N, et al. Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid β and impairment of learning and memory. Behav Brain Res, 2006, 168(1): 83-91 (Pubitemid 43152056)
19. Poirier R, Wolfer D P, Welzl H, et al. Neuronal neprilysin overexpression is associated with attenuation of Aβ-related spatial memory deficit. Neurobiol Dis, 2006, 24(3): 475-483 (Pubitemid 44716677)
20. Liu Y, Studzinski C, Beckett T, et al. Expression of neprilysin in skeletal muscle reduces amyloid burden in a transgenic mouse model of Alzheimer disease. Mol Ther, 2009, 17( 8): 1381-1386
21. Kanemitsu H, Tomiyama T, Mori H. Human neprilysin is capable of degrading amyloid β peptide not only in the monomelic form but also the pathological oligomeric form. Neurosci Lett, 2003, 350(2): 113-116 (Pubitemid 37101425)
22. Caccamo A, Oddo S, Sugarman M C, et al. Age and regiondependent alterations in Aβ-degrading enzymes: Implications for Aβ-induced disorders. Neurobiol Aging, 2005, 26( 5): 645-654
23. Wang R, Wang S, Malter J S, et al. Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells. J Neurochem, 2009, 108( 4): 1072-1082
24. Hellstrom-Lindahl E, Ravidb R, Nordberg A. Age-dependent decline of neprilysin in Alzheimer' s disease and normal brain: Inverse correlation with Aβ levels. Neurobiol Aging, 2008, 29( 2): 210-221
25. Wang S, Wang R, Chen L, et al. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain. J Neurochem, 2010, 115( 1): 47-57
26. Huang S M, Mouri A, Kokubo H, et al. Neprilysin-sensitive synapse-associated Aβ oligomers impair neuronal plasticity and cognitive function. J Biol Chem, 2006, 281(26): 17941-17951 (Pubitemid 44035593)
27. Leung K. K, Shen K K, Barnes J, et al. Increasing power to predict mild cognitive impairment conversion to Alzheimer's disease using hippocampal atrophy rate and statistical shape models. Med Image Comput Comput Assist Interv, 2010, 13( Pt2): 125-132
28. Albert M S, DeKosky S T, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the national institute on aging-alzheimer's association workgroups on diagnostic guidelines for alzheimer's disease. Alzheimers Dement, 2011, 7( 3): 270-279
29. McKhann G M, Knopman D S, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the national institute on aging-alzheimer's association workgroups on diagnostic guidelines for alzheimer's disease. Alzheimers Dement, 2011, 7( 3): 263-269
30. Mattsson N, Portelius E, Rolstad S, et al. Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment. J Alzheimers Dis, 2012, 30( 4): 767-778
31. Rodrigue K M, Kennedy K M, Devous M D Sr, et al. β-Amyloid burden in healthy aging: Regional distribution and cognitive consequences. Neurology, 2012, 78( 6): 387-395
32. Chételat G, Villemagne V L, Villain N, et al. Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition. Neurology, 2012, 78( 7): 477-484
33. Holler C J, Webb R L, Laux A L, et al. BACE2 expression increases in human neurodegenerative disease. Am J Pathol, 2012, 180( 1): 337-350
34. Austin B P, Nair V A, Meier T B, et al. Effects of hypoperfusion in Alzheimer's disease. J Alzheimers Dis, 2011, 26( Suppl 3): 123-133
35. Prasad K, Wiryasaputra L, Ng A, et al. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort. Dement Geriatr Cogn Disord, 2011, 31( 6): 431-434
36. Huang J Y, Hafez D M, James B D, et al. Altered NEP2 expression and activity in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis, 2012, 28( 2): 433-441
37. Maruyama M, Higuchi M, Takaki Y, et al. Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease. Ann Neurol, 2005, 57(6): 832-842 (Pubitemid 40798621)
38. Saito T, Iwata N, Tsubuki S, et al. Somatostatin regulates brain amyloid ß peptide Aβ42 through modulation of proteolytic degradation. Nat Med, 2005, 11(4): 434-439 (Pubitemid 40562335)
39. Saiz-Sanchez D, Ubeda-Banon I, de la Rosa-Prieto C, et al. Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease. Exp Neurol, 2010, 223( 2): 347-350
40. Sandoval K E, Farr S A, Banks W A, et al. Somatostatin receptor subtype-4 agonist NNC 26-9100 decreases extracellular and intracellular Aβ(1-42) trimers. Eur J Pharmacol, 2012, 683( 1- 3): 116-124
41. Liang K, Yang L, Yin C, et al. Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin. J Biol Chem, 2010, 285( 2): 935-942
42. Belyaev N D, Nalivaeva N N, Makova N Z, et al. Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter implications for Alzheimer's disease. EMBO Rep, 2009, 10( 1): 94-100
43. Pardossi-Piquard R, Petit A, Kawarai T, et al. Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron, 2005, 46(4): 541-554 (Pubitemid 40797380)
44. Bauer C, Pardossi-Piquard R, Dunys J, et al. γ-Secretase-mediated regulation of neprilysin: Influence of cell density and aging and modulation by imatinib. J Alzheimers Dis, 2011, 27( 3): 511-520
45. Nalivaeva N N, Belyaev N D, Lewis D I, et al. Effect of sodium Valproate administration on brain neprilysin expression and memory in rats. J Mol Neurosci, 2012, 46( 3): 569-577
46. Qing H, He G, Ly P T, et al. Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J Exp Med, 2008, 205( 12): 2781-2789
47. Huang H, Bihaqi S W, Cui L, et al. In vitro Pb exposure disturbs the balance between Aβ production and elimination: The role of AßPP and neprilysin. Neurotoxicology, 2011, 32( 3): 300-306
48. Wang Z, Yang D, Zhang X, et al. Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PLoS One, 2011, 6( 4): e19229
49. Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov, 2011, 10( 9): 698-712